News

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Mologic, Ltd. (Mologic), part of the recently formed social enterprise Global…

Cystatin C test: Developing a rapid test to allow users to track kidney function

Working with Bloom Diagnostics, Global Access Diagnostics (GADx) developed a Kidney Test to measure cystatin C level, a well-established indicator of kidney function. What is CKD? Kidneys play a vital role in filtering blood; removing…

An abstract representation of evolving pathways with diverging and converging lines that illustrate GADx's journey from inception to its current state and towards future opportunities. The design symbolizes strategic shifts, growth, and evolution under different leaderships, using a combination of flowing paths that embody progression and innovation. The image conveys an optimistic tone, highlighting the company's continuous forward movement and adaptation through changes in leadership.

Mologic to become a ‘Social Enterprise’ after acquisition by social impact funders and investors

A group of philanthropic funds and investors led by the Soros Economic Development Fund (SEDF), with support from the Bill & Melinda Gates Foundation, is today announcing the launch of Global Access Health (GAH), a…